Skip to main content

What the FDA labels say about taking them together

Clarithromycin and maraviroc

Clarithromycin's FDA label of April 9, 2026 names maraviroc in its drug interactions section; the maraviroc label PlainMeds reads does not name clarithromycin. The clarithromycin label: “Maraviroc Maraviroc: Clarithromycin may result in increases in maraviroc exposures by inhibition of CYP3A metabolism.”

Check it at the source: the clarithromycin FDA label on DailyMed (effective April 9, 2026, Solaris Pharma Corporation); the maraviroc FDA label on DailyMed (effective September 26, 2022, ViiV Healthcare Company).

What does the clarithromycin label say about maraviroc?

Clarithromycin label, drug interactions

Maraviroc Maraviroc: Clarithromycin may result in increases in maraviroc exposures by inhibition of CYP3A metabolism.

Source: FDA drug label (Clarithromycin), Solaris Pharma Corporation, effective April 9, 2026 (SPL set 4d42821d-ce7a-7d64-e063-6294a90a0875), via openFDA; the full label on DailyMed

What does the maraviroc label say about clarithromycin?

Maraviroc's label (effective September 26, 2022) does not name clarithromycin in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (SELZENTRY), ViiV Healthcare Company, effective September 26, 2022 (SPL set 46f30ac5-c96b-429e-976d-8c5ee1c0761b), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

26Clarithromycin generic labelers
8Maraviroc generic labelers
ClarithromycinMaraviroc
Labeled forBacterial infections, Acid reflux and ulcersHIV
Boxed warningNoYes
Pharmacy cost (NADAC)$0.466 per tablet 500 mg tablet$9.15 per tablet 150 mg tablet
Shortage nowNo current entryA presentation being discontinued

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?